Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids

Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jani M., Sivasubramanian, Geetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239863/
https://www.ncbi.nlm.nih.gov/pubmed/35731220
http://dx.doi.org/10.3201/eid2807.220198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239863/
https://www.ncbi.nlm.nih.gov/pubmed/35731220
http://dx.doi.org/10.3201/eid2807.220198

Ejemplares similares